search

Active clinical trials for "Hyperparathyroidism, Secondary"

Results 61-70 of 173

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary...

Secondary HyperparathyroidismDialysis

Prospective, non-randomized, multi-center study to assess the efficacy and safety of paricalcitol injection or oral administered over 6 months to patients with secondary hyperparathyroidism on dialysis.

Completed10 enrollment criteria

Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving...

Kidney DiseaseChronic Kidney Disease

The purpose of this study is to evaluate the efficacy and safety of cinacalcet compared with placebo in patients with stage 3 and 4 Chronic Kidney Disease (CKD).

Completed0 enrollment criteria

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium...

Secondary HyperparathyroidismChronic Kidney Disease

A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.

Completed18 enrollment criteria

SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism...

Secondary HyperparathyroidismEnd Stage Renal Disease

The purpose of this study is to demonstrate that the efficacy of cinacalcet when co-administered with the first meal after dialysis is comparable (non-inferior) to the efficacy of cinacalcet when administered during the dialysis study visit.

Completed0 enrollment criteria

A Study of Zemplar® Injection and Hectorol® Injection on Intestinal Absorption of Calcium in Chronic...

Chronic Kidney DiseaseStage 51 more

The purpose of this study is to evaluate the effects of Zemplar® Injection and Hectorol® Injection on intestinal calcium absorption in Chronic Kidney Disease Stage 5 subjects on hemodialysis.

Completed19 enrollment criteria

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

This study is designed to evaluate safety, pharmacokinetics and pharmacodynamics after single administration of KHK7580 for secondary hyperparathyroidism in patients receiving peritoneal dialysis.

Completed13 enrollment criteria

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism...

HyperparathyroidismSecondary

This study is designed to assess the efficacy and safety of etelcalcetide (AMG 416) compared with placebo in the treatment of SHPT in CKD patients receiving hemodialysis.

Completed15 enrollment criteria

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism...

Chronic Kidney DiseaseSecondary Hyperparathyroidism

This is a study to evaluate the safety and pharmacokinetics in pediatric patients with secondary hyperparathyroidism receiving a single dose of etelcalcetide at the end of hemodialysis.

Completed11 enrollment criteria

Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa)....

Secondary HyperparathyroidismChronic Kidney Disease-Mineral and Bone Disorder3 more

This is a pilot randomized controlled trial aimed to evaluate the effect of teriparatide on the clinical course of hypocalcemia after parathyroidectomy for secondary hyperparathyroidism in dialysis-dependent patients.

Completed10 enrollment criteria

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary...

HyperparathyroidismSecondary

The purpose of this study is to characterize the safety and tolerability of single rising doses of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism.

Completed11 enrollment criteria
1...678...18

Need Help? Contact our team!


We'll reach out to this number within 24 hrs